Lansdale, PA, United States of America

Shankar Venkatraman

USPTO Granted Patents = 28 

 

 

Average Co-Inventor Count = 8.7

ph-index = 4

Forward Citations = 45(Granted Patents)


Location History:

  • San Diego, CA (US) (2010)
  • Landsdale, PA (US) (2018 - 2023)
  • Lansdale, PA (US) (2013 - 2024)

Company Filing History:


Years Active: 2010-2025

where 'Filed Patents' based on already Granted Patents

28 patents (USPTO):

Title: The Innovation Journey of Shankar Venkatraman

Introduction:

Shankar Venkatraman, a prolific inventor based in Lansdale, PA (US), has made significant contributions to the field of pharmaceuticals with 23 patents to his name. His groundbreaking work focuses on developing inhibitors for crucial molecular interactions involved in cancer and other diseases.

Latest Patents:

Venkatraman's recent patents include "Inhibitors of the menin-MLL interaction" and "Compounds and compositions for treating conditions associated with NLRP activity." These inventions demonstrate his commitment to advancing medical treatments through innovative pharmaceutical solutions.

Career Highlights:

With a diverse professional background, Venkatraman has worked with renowned companies such as Vitae Pharmaceuticals, Inc. and Boehringer Ingelheim International GmbH. His expertise in drug discovery and development has been instrumental in shaping the industry's approach to combating complex diseases.

Collaborations:

Throughout his career, Shankar Venkatraman has collaborated closely with esteemed colleagues such as Yajun Zheng and Salvacion Cacatian. Together, they have fostered a culture of innovation and scientific excellence, leading to the successful creation of novel pharmaceutical products.

Conclusion:

In conclusion, Shankar Venkatraman's remarkable journey as an inventor showcases his unwavering dedication to transforming healthcare through pioneering research and development. His prolific patent portfolio and collaborative spirit are testaments to his enduring impact on the pharmaceutical industry and the broader scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…